SIDA E INFECCIONES VIH
Hospital Sierrallana
Torrelavega, EspañaPublicaciones en colaboración con investigadores/as de Hospital Sierrallana (5)
2018
-
Human immunodeficiency virus/hepatits C virus coinfection in Spain: Elimination is feasible, but the burden of residual cirrhosis will be significant
Open Forum Infectious Diseases, Vol. 5, Núm. 1
2017
-
Aetiology of renal failure in patients with infective endocarditis. The role of antibiotics
Medicina Clinica, Vol. 149, Núm. 8, pp. 331-338
2016
-
Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics
Open Forum Infectious Diseases, Vol. 3, Núm. 2
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2007
-
Effectiveness and safety of simplification therapy with once-daily tenofovir, lamivudine, and efavirenz in HIV-1-infected patients with undetectable plasma viral load on HAART
HIV Clinical Trials, Vol. 8, Núm. 5, pp. 328-336